Serum procalcitonin as a potential biomarker of surgery in parapneumonic pleural effusions Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Decreasing incidence of parapneumonic pleural effusions (PPE) in children Source: International Congress 2016 – Paediatric respiratory infections Year: 2016
Predictive factors, microbiology and outcome of patients with parapneumonic effusion Source: Eur Respir J 2011; 38: 1173-1179 Year: 2011
Protein profiling of pleural fluid in guiding management of infectious parapneumonic effusion in children Source: International Congress 2015 – Paediatric pulmonary infections Year: 2015
Serum procalcitonin concentrations in children with pulmonary tuberculosis, tuberculous infection and lober pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 176s Year: 2003
Human beta defensin-2 serum levels are lower in complicated infectious pleural effusions Source: Annual Congress 2013 –Interesting research questions Year: 2013
Metabolomic analysis of infectious parapneumonic effusions reveals biomarkers for management of children with streptococcus pneumoniae pneumonia Source: International Congress 2016 – Paediatric respiratory infection and immunology Year: 2016
Pneumonia in children, pleural infection, necrotising pneumonia and lung abscess Source: ERS Course 2019 - Summer school of paediatric respiratory medicine 2019 Year: 2019
Clinical analysis of 32 cases of biopsy-proven secondary organizing pneumonia following community-acquired pneumonia Source: International Congress 2014 – ILDs 4 Year: 2014
Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005
Necrotising pneumonia is an increasingly detected complication of pneumonia in children Source: Eur Respir J 2008; 31: 1285-1291 Year: 2008
Lung function of preschoolers with parapneumonic effusions complicating community acquired pneumonia Source: Annual Congress 2011 - Paediatric respiratory infection: signs, symptoms and sequelae Year: 2011
Evaluation of pleural fluid total protein, albumin, globulin levels and albumin/globulin ratios in the differential diagnosis of pleural effusions Source: International Congress 2016 – From pleura to bronchi: new insights Year: 2016
Pleural empyema in acute bacterial pneumonia in children Source: Eur Respir J 2004; 24: Suppl. 48, 715s Year: 2004
Serum indicators for the diagnosis of pneumocystis pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 559s Year: 2006
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections Year: 2013
Risk factors for parapneumonic effusion in community-asquired pneumonia Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019
Diagnostic accuracy of inflammatory biomarkers in bronchoalveolar lavage from patients with ventilator-associated pneumonia Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014
Molecular assay for tuberculous pleural effusion Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013
Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia Source: Eur Respir J 2008; 31: 356-362 Year: 2008